Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Antony Blinken cancels China trip following discovery of spy balloon
    • How much of a threat are Chinese spy balloons?
    • Nigeria’s attempt to replace its currency notes descends into chaos
    • US jobs total surges by over half a million in January
    • Madison Square Garden owner battles outcry over ‘dystopian’ blacklisting
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • TotalEnergies says exposure to Adani stands at $3.1bn as turmoil mounts
      • EY under fire over its two roles at battery start-up Britishvolt
      • BT chief warns Openreach fibre push will ‘end in tears’ for rivals
      • Billionaire Disney insider becomes pivotal figure in Nelson Peltz’s proxy fight
      • Swiss authorities open criminal probe into bank data breaches
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Middle-class Britons are the ‘new vulnerable’, says Tyrie
      • UK’s FTSE 100 share index beats 2018 peak to hit all-time high
      • Nigeria’s attempt to replace its currency notes descends into chaos
      • EU agrees price caps on Russian oil products
      • Crypto is back with $300bn frenzy
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
      Most Read
      • The worst airport in the world
      • Britain should not accept its status as the ‘sick man of Europe’
      • Tempting back older workers means ditching business as usual
      • Toyota has a tragic flaw in the electric vehicle drama
      • The Tate ruling is a victory against rubbernecking
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Barclays chief: the life lessons I have discovered during cancer treatment
      • Shoshana Zuboff: ‘Privacy has been extinguished. It is now a zombie’
      • A new generation refuses to keep quiet on age discrimination at work
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • After hours with 10 Foot, London’s most notorious graffiti writer
      • Germany grapples with the limits of pacifism
      • Rugby superstar Siya Kolisi: ‘I’ve got no ego at all’
      • Bill Gates is probed and baited in BBC interview with Amol Rajan — TV review
      • My downshift to deepest Spain
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Medical science

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 3 February, 2023
      First heart patients diagnosed using new fibre optic technology

      Researchers say device developed in London could help thousands suffering from vascular disease

    • Thursday, 2 February, 2023
      Neural implants in rats pave way to treat brain injuries

      Neuroscience breakthrough demonstrates ability of human organoids to adopt functions of host’s visual cortex

    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

    • Tuesday, 24 January, 2023
      Kate Bingham
      Britain is losing its chance to become a life sciences superpower

      Short-termism and suspicion in parts of government risk our valuable future in precision medicine

    • Tuesday, 17 January, 2023
      InterviewJenny Harries
      Covid will ‘taunt us’ for years, says UK health security chief

      Future of pandemic less predictable than at the outset because of new variants, says Jenny Harries

    • Wednesday, 11 January, 2023
      Anjana Ahuja
      New Alzheimer’s drug straddles uneasy gulf between help and harm

      For all its landmark status, lecanemab may end up representing a triumph of hope over evidence

    • Tuesday, 10 January, 2023
      Coronavirus pandemic
      China suspends travel visas from Japan and S Korea over Covid curbs

      Beijing accuses countries of ‘political manipulation’ for introducing testing requirements during exit wave

    • Monday, 9 January, 2023
      Disrupted Times
      World awaits return of Chinese tourists

      Also in this edition: eurozone unemployment falls to new low, uproar in Brazil and Rolls-Royce hits sales record

    • Sunday, 8 January, 2023
      Alphabet’s Verily seeks to eradicate dengue in Singapore

      Bid to extend tech throughout city state to wipe out disease-carrying mosquito population

    • Friday, 6 January, 2023
      UK signs deal with BioNTech for cutting-edge cancer trials

      Covid-19 vaccine maker hails ‘huge’ investment aimed at recruiting 10,000 participants with NHS

    • Thursday, 5 January, 2023
      ExplainerCoronavirus pandemic
      How serious is the threat of new Covid-19 variants?

      A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge

    • Thursday, 5 January, 2023
      The Big Read
      The UK’s dream of becoming a ‘science superpower’

      Ministers want to supercharge the £89bn life science industry. But it will take long-term thinking on investment, talent and infrastructure

    • Wednesday, 4 January, 2023
      Coronavirus pandemic
      China has under-represented its number of Covid deaths, says WHO

      Global health body issues its strongest rebuke yet of Beijing’s handling of the pandemic

    • Wednesday, 4 January, 2023
      Anjana Ahuja
      We may be entering Covid’s least predictable year yet

      China’s unleashing of the virus is raising questions about the potential for harmful, new variants

    • Tuesday, 3 January, 2023
      LexChinese business & finance
      China banks: Covid will eclipse property woe this new year Premium content

      Chinese authorities will expect big banks to support struggling enterprises with soft loans and outright rescues

    • Tuesday, 3 January, 2023
      The Big Read
      China’s Covid generation: the surging inequality behind Xi’s U-turn

      Lockdowns have often been more relentless in rural areas, upending the education of millions and blocking social mobility

    • Monday, 2 January, 2023
      LexDrugs research
      Moderna/BioNTech: cancer vaccines will show mRNA not a one-trick pony Premium content

      Success in battle against Covid does not ensure success against tumours, but should narrow the odds

    • Sunday, 1 January, 2023
      News in-depthChinese politics & policy
      Xi’s credibility ‘badly wounded’ as China’s Covid death toll mounts

      Beijing’s war games with Russia and aggression against Taiwan fail to distract from public health crisis

    • Friday, 30 December, 2022
      Genomics
      UK to embark on groundbreaking new genomics projects

      Programmes involving millions of volunteers will cement Britain’s place as leader in DNA research

    • Thursday, 29 December, 2022
      Coronavirus pandemic
      UK weighs Covid restrictions for travellers from China

      Move comes as US, Japan and India introduce tests and EU debates issue with Italy

    • Thursday, 29 December, 2022
      Coronavirus pandemic
      EU rejects Italian demand to impose Covid curbs on arrivals from China

      France, Germany and other states say situation does not warrant change in coronavirus policies

    • Thursday, 29 December, 2022
      The FT ViewThe editorial board
      World must be vigilant amid China’s Covid reopening

      There are echoes of early 2020 in Xi’s policy of obfuscation

    • Wednesday, 28 December, 2022
      Hong Kong
      Hong Kong abandons last Covid curbs to revive economy

      Territory drops mandatory testing for arrivals as it follows Beijing’s exit from virus controls

    • Wednesday, 28 December, 2022
      OutlookJoe Leahy
      Exit from zero-Covid is no easy path for China

      Forced to abandon its draconian policy, Beijing’s unconvincing narrative cannot hide its lack of preparation

    • Wednesday, 28 December, 2022
      News in-depthDrugs research
      Race is on to develop new generation of weight-loss drugs

      Eli Lilly, Amgen, Pfizer and Regeneron follow Novo Nordisk into obesity treatments worth billions

    Previous page You are on page 1 Next page

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsSecondary Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition
    • Top sections
    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • The Big Read
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports
    • FT recommends
    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • FTfm
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In